Balentine LLC Edwards Lifesciences Corp Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $503,209 - $662,899	6,937 Added 143.53%	11,770 $1.12 Million
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $298,244 - $375,814	4,833 New	4,833 $368,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $95,493 - $110,649	1,173 Added 37.31%	4,317 $407,000
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $233,473 - $265,699	3,144 New	3,144 $260,000
Q3 2022 Oct 26, 2022	BUY	$82.37 - $107.29 $92,501 - $120,486	1,123 Added 30.41%	4,816 $398,000
Q2 2022 Oct 26, 2022	SELL	$86.5 - $128.27 $70,065 - $103,898	-810 Reduced 17.99%	3,693 $351,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $319,444 - $473,701	3,693 New	3,693 $351,000
Q1 2022 Oct 26, 2022	BUY	$101.96 - $128.34 $82,587 - $103,955	810 Added 21.93%	4,503 $530,000
Q4 2021 Oct 26, 2022	SELL	$106.37 - $130.68 $125,091 - $153,679	-1,176 Reduced 31.84%	2,517 $326,000
Q4 2021 Feb 02, 2022	SELL	$106.37 - $130.68 $218,696 - $268,678	-2,056 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$102.91 - $122.75 $211,582 - $252,374	2,056 New	2,056 $233,000
Q3 2020 Nov 02, 2020	SELL	$67.19 - $87.44 $38,701 - $50,365	-576 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $23,476 - $31,395	408 Added 242.86%	576 $40,000
Q1 2020 May 18, 2020	SELL	$52.41 - $81.0 $10,901 - $16,848	-208 Reduced 55.32%	168 $32,000
Q4 2019 Sep 02, 2020	BUY	$71.7 - $82.09 $14,340 - $16,418	200 Added 113.64%	376 $88,000
Q3 2019 Nov 15, 2019	BUY	$61.55 - $75.43 $1,354 - $1,659	22 Added 14.29%	176 $39,000
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $1,449 - $1,674	26 Added 20.31%	154 $28,000
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $5,849 - $7,427	128 New	128 $22,000
Q1 2018 May 16, 2018	SELL	$37.19 - $47.45 $45,929 - $58,600	-1,235 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $9,799 - $11,423	290 Added 30.69%	1,235 $139,000
Q3 2017 Nov 15, 2017	BUY	$36.29 - $38.83 $34,294 - $36,694	945	945 $103,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account